September 30, 2006
Deep brain stimulation is an innovative way to control severe tremor or some of the motor symptoms of Parkinson’s disease. This medical device was approved by the FDA in 1997 for treatment of patients with severe tremor that was not controlled by medications. A few years later, it was approved for treatment of Parkinson tremor [...]
Read the full article →
September 27, 2006
The FDA recently approved a new Parkinson medication for use in patients that are having problems with off time and freezing. The new drug is called Zelapar. It is a rapidly dissolving tablet whose active ingredient is selegeline. Many of you may have tried selegiline in the past (marketed as Eldepryl.) The new formulation of [...]
Read the full article →